Global Niemann-Pick Disease Market
Global Niemann-Pick Disease Market

Niemann-Pick Disease Comprehensive Study by Type (Niemann-Pick Type A, Niemann-Pick Type B, Niemann-Pick Type C), Treatment (Bone Marrow Transplantation, Enzyme Replacement, Gene Therapies), End-users (Hospitals, Clinics, Others), Diagnosis (Urinalysis, Understanding pH Levels), Symptoms (Vomiting, Diarrhea, Fatigue, Others) Players and Region - Global Market Outlook to 2025

Niemann-Pick Disease Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Nov 2020 Edition 220 Pages 215 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Niemann-Pick Disease Market?

Niemann-pick disease is a rare, inherited disease that affects the body's ability to metabolize fat (cholesterol and lipids) within cells. It has an abnormal lipid metabolism that causes a buildup of harmful amounts of lipids in various organs. Its signs and symptoms may involve clumsiness and difficulty walking, excessive muscle contractions or eye movements, sleep disturbances, difficulty swallowing and eating, recurrent pneumonia and others. The factors such as Increased Number of Diagnostic Centres and Increasing Prevalence of Niemann-Pick Disease are driving the global Niemann-Pick Disease market.

The market study is being classified by Type (Niemann-Pick Type A, Niemann-Pick Type B and Niemann-Pick Type C) and major geographies with country level break-up.

Sanofi Genzyme (United States), Aldagen Inc. (United States), Alexion Pharmaceuticals Inc. (United States), CTD Holdings, Inc. (United States), Orphazyme ApS (Denmark), Actelion Pharmaceuticals Ltd (Switzerland), Vtesse Inc. (United States), Merck & Co., Inc. (United States) and Okklo Life Sciences BV (Netherlands) are some of the key players profiled in the study.

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Niemann-Pick Disease market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Niemann-Pick Disease market by Type, Application and Region.

On the basis of geography, the market of Niemann-Pick Disease has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increased Number of Diagnostic Centres
  • Increasing Prevalence of Niemann-Pick Disease

Market Trend
  • Increasing Awareness among People about Healthy LIfestyle

Restraints
  • Non-Avaialability of Total Cure for Niemann-Pick Disease

Opportunities
  • Growth in the Healthcare Industry Worldwide
  • Technological Advancement in Medical Science

Challenges
  • Stringent Government Rules and Regulations


In September 2019, CTD Holdings, Inc., a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with an unmet medical need, today announced that the company will provide Trappsol Cyclo, its proprietary hydroxypropyl beta-cyclodextrin drug, to a pediatric patient diagnosed with Niemann-Pick Disease Type C.


Key Target Audience
Niemann-Pick Disease Treatment Providers, Distributors, Emerging Companies, Research Professionals and End-users

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Niemann-Pick Type A
  • Niemann-Pick Type B
  • Niemann-Pick Type C
By Treatment
  • Bone Marrow Transplantation
  • Enzyme Replacement
  • Gene Therapies

By End-users
  • Hospitals
  • Clinics
  • Others

By Diagnosis
  • Urinalysis
  • Understanding pH Levels

By Symptoms
  • Vomiting
  • Diarrhea
  • Fatigue
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Number of Diagnostic Centres
      • 3.2.2. Increasing Prevalence of Niemann-Pick Disease
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Increasing Awareness among People about Healthy LIfestyle
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Niemann-Pick Disease, by Type, Treatment, End-users, Diagnosis, Symptoms and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Niemann-Pick Disease (Value)
      • 5.2.1. Global Niemann-Pick Disease by: Type (Value)
        • 5.2.1.1. Niemann-Pick Type A
        • 5.2.1.2. Niemann-Pick Type B
        • 5.2.1.3. Niemann-Pick Type C
      • 5.2.2. Global Niemann-Pick Disease by: Treatment (Value)
        • 5.2.2.1. Bone Marrow Transplantation
        • 5.2.2.2. Enzyme Replacement
        • 5.2.2.3. Gene Therapies
      • 5.2.3. Global Niemann-Pick Disease by: End-users (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Others
      • 5.2.4. Global Niemann-Pick Disease by: Diagnosis (Value)
        • 5.2.4.1. Urinalysis
        • 5.2.4.2. Understanding pH Levels
      • 5.2.5. Global Niemann-Pick Disease by: Symptoms (Value)
        • 5.2.5.1. Vomiting
        • 5.2.5.2. Diarrhea
        • 5.2.5.3. Fatigue
        • 5.2.5.4. Others
      • 5.2.6. Global Niemann-Pick Disease Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Niemann-Pick Disease: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sanofi Genzyme (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Aldagen Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Alexion Pharmaceuticals Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. CTD Holdings, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Orphazyme ApS (Denmark)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Actelion Pharmaceuticals Ltd (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Vtesse Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Merck & Co., Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Okklo Life Sciences BV (Netherlands)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Niemann-Pick Disease Sale, by Type, Treatment, End-users, Diagnosis, Symptoms and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Niemann-Pick Disease (Value)
      • 7.2.1. Global Niemann-Pick Disease by: Type (Value)
        • 7.2.1.1. Niemann-Pick Type A
        • 7.2.1.2. Niemann-Pick Type B
        • 7.2.1.3. Niemann-Pick Type C
      • 7.2.2. Global Niemann-Pick Disease by: Treatment (Value)
        • 7.2.2.1. Bone Marrow Transplantation
        • 7.2.2.2. Enzyme Replacement
        • 7.2.2.3. Gene Therapies
      • 7.2.3. Global Niemann-Pick Disease by: End-users (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Others
      • 7.2.4. Global Niemann-Pick Disease by: Diagnosis (Value)
        • 7.2.4.1. Urinalysis
        • 7.2.4.2. Understanding pH Levels
      • 7.2.5. Global Niemann-Pick Disease by: Symptoms (Value)
        • 7.2.5.1. Vomiting
        • 7.2.5.2. Diarrhea
        • 7.2.5.3. Fatigue
        • 7.2.5.4. Others
      • 7.2.6. Global Niemann-Pick Disease Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Niemann-Pick Disease: by Type(USD Million)
  • Table 2. Niemann-Pick Disease Niemann-Pick Type A , by Region USD Million (2014-2019)
  • Table 3. Niemann-Pick Disease Niemann-Pick Type B , by Region USD Million (2014-2019)
  • Table 4. Niemann-Pick Disease Niemann-Pick Type C , by Region USD Million (2014-2019)
  • Table 5. Niemann-Pick Disease: by Treatment(USD Million)
  • Table 6. Niemann-Pick Disease Bone Marrow Transplantation , by Region USD Million (2014-2019)
  • Table 7. Niemann-Pick Disease Enzyme Replacement , by Region USD Million (2014-2019)
  • Table 8. Niemann-Pick Disease Gene Therapies , by Region USD Million (2014-2019)
  • Table 9. Niemann-Pick Disease: by End-users(USD Million)
  • Table 10. Niemann-Pick Disease Hospitals , by Region USD Million (2014-2019)
  • Table 11. Niemann-Pick Disease Clinics , by Region USD Million (2014-2019)
  • Table 12. Niemann-Pick Disease Others , by Region USD Million (2014-2019)
  • Table 13. Niemann-Pick Disease: by Diagnosis(USD Million)
  • Table 14. Niemann-Pick Disease Urinalysis , by Region USD Million (2014-2019)
  • Table 15. Niemann-Pick Disease Understanding pH Levels , by Region USD Million (2014-2019)
  • Table 16. Niemann-Pick Disease: by Symptoms(USD Million)
  • Table 17. Niemann-Pick Disease Vomiting , by Region USD Million (2014-2019)
  • Table 18. Niemann-Pick Disease Diarrhea , by Region USD Million (2014-2019)
  • Table 19. Niemann-Pick Disease Fatigue , by Region USD Million (2014-2019)
  • Table 20. Niemann-Pick Disease Others , by Region USD Million (2014-2019)
  • Table 21. South America Niemann-Pick Disease, by Country USD Million (2014-2019)
  • Table 22. South America Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 23. South America Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 24. South America Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 25. South America Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 26. South America Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 27. Brazil Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 28. Brazil Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 29. Brazil Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 30. Brazil Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 31. Brazil Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 32. Argentina Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 33. Argentina Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 34. Argentina Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 35. Argentina Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 36. Argentina Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 37. Rest of South America Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 38. Rest of South America Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 39. Rest of South America Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 40. Rest of South America Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 41. Rest of South America Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 42. Asia Pacific Niemann-Pick Disease, by Country USD Million (2014-2019)
  • Table 43. Asia Pacific Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 44. Asia Pacific Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 45. Asia Pacific Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 46. Asia Pacific Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 47. Asia Pacific Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 48. China Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 49. China Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 50. China Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 51. China Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 52. China Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 53. Japan Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 54. Japan Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 55. Japan Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 56. Japan Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 57. Japan Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 58. India Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 59. India Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 60. India Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 61. India Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 62. India Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 63. South Korea Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 64. South Korea Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 65. South Korea Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 66. South Korea Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 67. South Korea Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 68. Taiwan Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 69. Taiwan Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 70. Taiwan Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 71. Taiwan Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 72. Taiwan Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 73. Australia Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 74. Australia Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 75. Australia Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 76. Australia Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 77. Australia Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 78. Rest of Asia-Pacific Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 79. Rest of Asia-Pacific Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 80. Rest of Asia-Pacific Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 81. Rest of Asia-Pacific Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 82. Rest of Asia-Pacific Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 83. Europe Niemann-Pick Disease, by Country USD Million (2014-2019)
  • Table 84. Europe Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 85. Europe Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 86. Europe Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 87. Europe Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 88. Europe Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 89. Germany Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 90. Germany Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 91. Germany Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 92. Germany Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 93. Germany Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 94. France Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 95. France Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 96. France Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 97. France Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 98. France Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 99. Italy Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 100. Italy Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 101. Italy Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 102. Italy Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 103. Italy Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 104. United Kingdom Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 105. United Kingdom Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 106. United Kingdom Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 107. United Kingdom Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 108. United Kingdom Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 109. Netherlands Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 110. Netherlands Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 111. Netherlands Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 112. Netherlands Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 113. Netherlands Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 114. Rest of Europe Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 115. Rest of Europe Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 116. Rest of Europe Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 117. Rest of Europe Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 118. Rest of Europe Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 119. MEA Niemann-Pick Disease, by Country USD Million (2014-2019)
  • Table 120. MEA Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 121. MEA Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 122. MEA Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 123. MEA Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 124. MEA Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 125. Middle East Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 126. Middle East Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 127. Middle East Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 128. Middle East Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 129. Middle East Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 130. Africa Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 131. Africa Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 132. Africa Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 133. Africa Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 134. Africa Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 135. North America Niemann-Pick Disease, by Country USD Million (2014-2019)
  • Table 136. North America Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 137. North America Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 138. North America Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 139. North America Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 140. North America Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 141. United States Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 142. United States Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 143. United States Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 144. United States Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 145. United States Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 146. Canada Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 147. Canada Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 148. Canada Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 149. Canada Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 150. Canada Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 151. Mexico Niemann-Pick Disease, by Type USD Million (2014-2019)
  • Table 152. Mexico Niemann-Pick Disease, by Treatment USD Million (2014-2019)
  • Table 153. Mexico Niemann-Pick Disease, by End-users USD Million (2014-2019)
  • Table 154. Mexico Niemann-Pick Disease, by Diagnosis USD Million (2014-2019)
  • Table 155. Mexico Niemann-Pick Disease, by Symptoms USD Million (2014-2019)
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Niemann-Pick Disease: by Type(USD Million)
  • Table 166. Niemann-Pick Disease Niemann-Pick Type A , by Region USD Million (2020-2025)
  • Table 167. Niemann-Pick Disease Niemann-Pick Type B , by Region USD Million (2020-2025)
  • Table 168. Niemann-Pick Disease Niemann-Pick Type C , by Region USD Million (2020-2025)
  • Table 169. Niemann-Pick Disease: by Treatment(USD Million)
  • Table 170. Niemann-Pick Disease Bone Marrow Transplantation , by Region USD Million (2020-2025)
  • Table 171. Niemann-Pick Disease Enzyme Replacement , by Region USD Million (2020-2025)
  • Table 172. Niemann-Pick Disease Gene Therapies , by Region USD Million (2020-2025)
  • Table 173. Niemann-Pick Disease: by End-users(USD Million)
  • Table 174. Niemann-Pick Disease Hospitals , by Region USD Million (2020-2025)
  • Table 175. Niemann-Pick Disease Clinics , by Region USD Million (2020-2025)
  • Table 176. Niemann-Pick Disease Others , by Region USD Million (2020-2025)
  • Table 177. Niemann-Pick Disease: by Diagnosis(USD Million)
  • Table 178. Niemann-Pick Disease Urinalysis , by Region USD Million (2020-2025)
  • Table 179. Niemann-Pick Disease Understanding pH Levels , by Region USD Million (2020-2025)
  • Table 180. Niemann-Pick Disease: by Symptoms(USD Million)
  • Table 181. Niemann-Pick Disease Vomiting , by Region USD Million (2020-2025)
  • Table 182. Niemann-Pick Disease Diarrhea , by Region USD Million (2020-2025)
  • Table 183. Niemann-Pick Disease Fatigue , by Region USD Million (2020-2025)
  • Table 184. Niemann-Pick Disease Others , by Region USD Million (2020-2025)
  • Table 185. South America Niemann-Pick Disease, by Country USD Million (2020-2025)
  • Table 186. South America Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 187. South America Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 188. South America Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 189. South America Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 190. South America Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 191. Brazil Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 192. Brazil Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 193. Brazil Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 194. Brazil Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 195. Brazil Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 196. Argentina Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 197. Argentina Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 198. Argentina Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 199. Argentina Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 200. Argentina Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 201. Rest of South America Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 202. Rest of South America Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 203. Rest of South America Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 204. Rest of South America Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 205. Rest of South America Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 206. Asia Pacific Niemann-Pick Disease, by Country USD Million (2020-2025)
  • Table 207. Asia Pacific Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 208. Asia Pacific Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 209. Asia Pacific Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 210. Asia Pacific Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 211. Asia Pacific Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 212. China Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 213. China Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 214. China Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 215. China Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 216. China Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 217. Japan Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 218. Japan Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 219. Japan Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 220. Japan Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 221. Japan Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 222. India Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 223. India Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 224. India Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 225. India Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 226. India Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 227. South Korea Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 228. South Korea Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 229. South Korea Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 230. South Korea Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 231. South Korea Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 232. Taiwan Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 233. Taiwan Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 234. Taiwan Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 235. Taiwan Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 236. Taiwan Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 237. Australia Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 238. Australia Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 239. Australia Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 240. Australia Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 241. Australia Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 242. Rest of Asia-Pacific Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 243. Rest of Asia-Pacific Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 244. Rest of Asia-Pacific Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 245. Rest of Asia-Pacific Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 246. Rest of Asia-Pacific Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 247. Europe Niemann-Pick Disease, by Country USD Million (2020-2025)
  • Table 248. Europe Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 249. Europe Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 250. Europe Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 251. Europe Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 252. Europe Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 253. Germany Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 254. Germany Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 255. Germany Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 256. Germany Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 257. Germany Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 258. France Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 259. France Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 260. France Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 261. France Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 262. France Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 263. Italy Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 264. Italy Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 265. Italy Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 266. Italy Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 267. Italy Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 268. United Kingdom Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 269. United Kingdom Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 270. United Kingdom Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 271. United Kingdom Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 272. United Kingdom Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 273. Netherlands Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 274. Netherlands Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 275. Netherlands Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 276. Netherlands Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 277. Netherlands Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 278. Rest of Europe Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 279. Rest of Europe Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 280. Rest of Europe Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 281. Rest of Europe Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 282. Rest of Europe Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 283. MEA Niemann-Pick Disease, by Country USD Million (2020-2025)
  • Table 284. MEA Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 285. MEA Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 286. MEA Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 287. MEA Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 288. MEA Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 289. Middle East Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 290. Middle East Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 291. Middle East Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 292. Middle East Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 293. Middle East Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 294. Africa Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 295. Africa Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 296. Africa Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 297. Africa Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 298. Africa Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 299. North America Niemann-Pick Disease, by Country USD Million (2020-2025)
  • Table 300. North America Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 301. North America Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 302. North America Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 303. North America Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 304. North America Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 305. United States Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 306. United States Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 307. United States Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 308. United States Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 309. United States Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 310. Canada Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 311. Canada Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 312. Canada Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 313. Canada Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 314. Canada Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 315. Mexico Niemann-Pick Disease, by Type USD Million (2020-2025)
  • Table 316. Mexico Niemann-Pick Disease, by Treatment USD Million (2020-2025)
  • Table 317. Mexico Niemann-Pick Disease, by End-users USD Million (2020-2025)
  • Table 318. Mexico Niemann-Pick Disease, by Diagnosis USD Million (2020-2025)
  • Table 319. Mexico Niemann-Pick Disease, by Symptoms USD Million (2020-2025)
  • Table 320. Research Programs/Design for This Report
  • Table 321. Key Data Information from Secondary Sources
  • Table 322. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Niemann-Pick Disease: by Type USD Million (2014-2019)
  • Figure 5. Global Niemann-Pick Disease: by Treatment USD Million (2014-2019)
  • Figure 6. Global Niemann-Pick Disease: by End-users USD Million (2014-2019)
  • Figure 7. Global Niemann-Pick Disease: by Diagnosis USD Million (2014-2019)
  • Figure 8. Global Niemann-Pick Disease: by Symptoms USD Million (2014-2019)
  • Figure 9. South America Niemann-Pick Disease Share (%), by Country
  • Figure 10. Asia Pacific Niemann-Pick Disease Share (%), by Country
  • Figure 11. Europe Niemann-Pick Disease Share (%), by Country
  • Figure 12. MEA Niemann-Pick Disease Share (%), by Country
  • Figure 13. North America Niemann-Pick Disease Share (%), by Country
  • Figure 14. Global Niemann-Pick Disease share by Players 2019 (%)
  • Figure 15. Global Niemann-Pick Disease share by Players (Top 3) 2019(%)
  • Figure 16. Global Niemann-Pick Disease share by Players (Top 5) 2019(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Sanofi Genzyme (United States) Revenue, Net Income and Gross profit
  • Figure 19. Sanofi Genzyme (United States) Revenue: by Geography 2019
  • Figure 20. Aldagen Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Aldagen Inc. (United States) Revenue: by Geography 2019
  • Figure 22. Alexion Pharmaceuticals Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Alexion Pharmaceuticals Inc. (United States) Revenue: by Geography 2019
  • Figure 24. CTD Holdings, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. CTD Holdings, Inc. (United States) Revenue: by Geography 2019
  • Figure 26. Orphazyme ApS (Denmark) Revenue, Net Income and Gross profit
  • Figure 27. Orphazyme ApS (Denmark) Revenue: by Geography 2019
  • Figure 28. Actelion Pharmaceuticals Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 29. Actelion Pharmaceuticals Ltd (Switzerland) Revenue: by Geography 2019
  • Figure 30. Vtesse Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Vtesse Inc. (United States) Revenue: by Geography 2019
  • Figure 32. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Merck & Co., Inc. (United States) Revenue: by Geography 2019
  • Figure 34. Okklo Life Sciences BV (Netherlands) Revenue, Net Income and Gross profit
  • Figure 35. Okklo Life Sciences BV (Netherlands) Revenue: by Geography 2019
  • Figure 36. Global Niemann-Pick Disease: by Type USD Million (2020-2025)
  • Figure 37. Global Niemann-Pick Disease: by Treatment USD Million (2020-2025)
  • Figure 38. Global Niemann-Pick Disease: by End-users USD Million (2020-2025)
  • Figure 39. Global Niemann-Pick Disease: by Diagnosis USD Million (2020-2025)
  • Figure 40. Global Niemann-Pick Disease: by Symptoms USD Million (2020-2025)
  • Figure 41. South America Niemann-Pick Disease Share (%), by Country
  • Figure 42. Asia Pacific Niemann-Pick Disease Share (%), by Country
  • Figure 43. Europe Niemann-Pick Disease Share (%), by Country
  • Figure 44. MEA Niemann-Pick Disease Share (%), by Country
  • Figure 45. North America Niemann-Pick Disease Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Sanofi Genzyme (United States)
  • Aldagen Inc. (United States)
  • Alexion Pharmaceuticals Inc. (United States)
  • CTD Holdings, Inc. (United States)
  • Orphazyme ApS (Denmark)
  • Actelion Pharmaceuticals Ltd (Switzerland)
  • Vtesse Inc. (United States)
  • Merck & Co., Inc. (United States)
  • Okklo Life Sciences BV (Netherlands)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation